We are grateful that the 9th International Influenza Meeting is financially supported with € 300 by:
Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs is proud to be a world leader in the discovery and production of enzymes for molecular biology applications.
Over the last 50 years, NEB has expanded its product offerings into areas such as PCR, gene expression, sample preparation for next-generation sequencing, synthetic biology, glycobiology, epigenetics, and RNA analysis. Additionally, NEB is dedicated to strengthening alliances to bring new technologies to key market sectors, including molecular diagnostics and nucleic acid vaccines.
At NEB, we prioritize the advancement of science, environmental stewardship, and giving back to the community. Our profits fuel extensive research programs, ensuring that we remain at the forefront of scientific innovation.
As we reflect on our history and look to the future, we are committed to supporting researchers in addressing the complex challenges of today's world. Together, we can shape the science of tomorrow and make a positive impact on the world around us.
